1. A transformer-based deep learning model for early prediction of lymph node metastasis in locally advanced gastric cancer after neoadjuvant chemotherapy using pretreatment CT imagesResearch in context
- Author
-
Yunlin Zheng, Bingjiang Qiu, Shunli Liu, Ruirui Song, Xianqi Yang, Lei Wu, Zhihong Chen, Abudouresuli Tuersun, Xiaotang Yang, Wei Wang, and Zaiyi Liu
- Subjects
Deep learning ,Lymph node metastasis ,Locally advanced gastric cancer ,Neoadjuvant chemotherapy ,Early prediction ,Medicine (General) ,R5-920 - Abstract
Summary: Background: Early prediction of lymph node status after neoadjuvant chemotherapy (NAC) facilitates promptly optimization of treatment strategies. This study aimed to develop and validate a deep learning network (DLN) using baseline computed tomography images to predict lymph node metastasis (LNM) after NAC in patients with locally advanced gastric cancer (LAGC). Methods: A total of 1205 LAGC patients were retrospectively recruited from three hospitals between January 2013 and March 2023, constituting a training cohort, an internal validation cohort, and two external validation cohorts. A transformer-based DLN was developed using 3D tumor images to predict LNM after NAC. A clinical model was constructed through multivariate logistic regression analysis as a baseline for subsequent comparisons. The performance of the models was evaluated through discrimination, calibration, and clinical applicability. Furthermore, Kaplan–Meier survival analysis was conducted to assess overall survival (OS) of LAGC patients at two follow-up centers. Findings: The DLN outperformed the clinical model and demonstrated a robust performance for predicting LNM in the training and validation cohorts, with areas under the curve (AUCs) of 0.804 (95% confidence interval [CI], 0.752–0.849), 0.748 (95% CI, 0.660–0.830), 0.788 (95% CI, 0.735–0.835), and 0.766 (95% CI, 0.717–0.814), respectively. Decision curve analysis exhibited a high net clinical benefit of the DLN. Moreover, the DLN was significantly associated with the OS of LAGC patients [Center 1: hazard ratio (HR), 1.789, P
- Published
- 2024
- Full Text
- View/download PDF